CPhI India Pre-Connect Congress

The Indian pharma industry continues to face disruptions from evolving regulatory landscapes and growing market complexities. It is in the phase to regain its growth momentum in coming years. Increasing protectionist measures and pricing concerns in the global markets tend to put a lot of pressure on India companies with respect to market access and business viability.

Increasing private sector investments in R&D and acquisitions are driving the pharmaceutical sector grow. According to recent update by IBEF, Indian pharmaceutical companies invested 8.8% of their sales in R&D

Medicine spending in India is projected to grow 9-12% over the next five years, leading India to become one of the top 10 countries in terms of medicine spending. With the increasing regulatory scrutiny Indian pharmaceutical companies need to adapt to the changing landscape, and emerge stronger. Artificial intelligence (AI), Machine learning are growing technologies that are finding applications in all aspects of life and industry to enhance efficiency in the pharmaceutical drug discovery.

Considering the paradigm shift in the Indian pharmaceutical industry, CPhI India is pleased to organize the Pre-Connect Congress which will be held on 24th November 2020 in Greater Noida. Driven by powerful content the forum promises to provide a unique opportunity to bring all key stakeholders in the pharmaceutical industry on a single platform to discuss, deliberate and share their thoughts on achieving the next phase of growth!

With presentations, case studies and interactive panel discussions, utilize this exciting opportunity to meet and hear from renowned leaders in the industry. The audience will benefit from discussions revolving around Research and Development, Innovations, Drug Discovery, Artificial Intelligence, Portfolio diversification and Regulatory compliance.